- Home
- ICLR vs DECK Comparison
ICLR vs DECK Comparison
Compare ICLR & DECK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLR
- DECK
- Stock Information
- Founded
- ICLR 1990
- DECK 1973
- Country
- ICLR Ireland
- DECK United States
- Employees
- ICLR N/A
- DECK N/A
- Industry
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- DECK Shoe Manufacturing
- Sector
- ICLR Health Care
- DECK Consumer Discretionary
- Exchange
- ICLR Nasdaq
- DECK Nasdaq
- Market Cap
- ICLR 13.7B
- DECK 15.7B
- IPO Year
- ICLR 1998
- DECK 1993
- Fundamental
- Price
- ICLR $173.13
- DECK $118.72
- Analyst Decision
- ICLR Buy
- DECK Buy
- Analyst Count
- ICLR 15
- DECK 22
- Target Price
- ICLR $209.93
- DECK $140.39
- AVG Volume (30 Days)
- ICLR 1.1M
- DECK 2.5M
- Earning Date
- ICLR 10-22-2025
- DECK 10-23-2025
- Dividend Yield
- ICLR N/A
- DECK N/A
- EPS Growth
- ICLR 13.11
- DECK 24.88
- EPS
- ICLR 9.73
- DECK 6.53
- Revenue
- ICLR $8,089,820,000.00
- DECK $5,124,803,000.00
- Revenue This Year
- ICLR N/A
- DECK $11.62
- Revenue Next Year
- ICLR $1.73
- DECK $8.03
- P/E Ratio
- ICLR $17.51
- DECK $18.14
- Revenue Growth
- ICLR N/A
- DECK 15.49
- 52 Week Low
- ICLR $125.10
- DECK $93.72
- 52 Week High
- ICLR $310.54
- DECK $223.98
- Technical
- Relative Strength Index (RSI)
- ICLR 51.75
- DECK 59.33
- Support Level
- ICLR N/A
- DECK $113.53
- Resistance Level
- ICLR $176.07
- DECK $120.30
- Average True Range (ATR)
- ICLR 6.17
- DECK 3.31
- MACD
- ICLR -7.19
- DECK -0.27
- Stochastic Oscillator
- ICLR 94.78
- DECK 43.54
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About DECK Deckers Outdoor Corporation
Founded in 1973, California-based Deckers designs and sells casual and performance footwear, apparel, and accessories. In fiscal 2025, Ugg and Hoka accounted for 51% and 45% of total sales, respectively. The firm also markets niche brands Teva and Ahnu. Deckers produces most of its sales through wholesale partnerships but also operates e-commerce in more than 50 countries and about 180 company-operated stores. It generated 64% of its fiscal 2025 sales in the United States.